|Articles|January 1, 2012
- Pharmaceutical Executive-01-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2012
Industry Forecast 2012 : Bridging the Divide
Advertisement
Articles in this issue
over 14 years ago
Hungary Report: Redefining Sustainabilityover 14 years ago
Emerging Markets: Bridging the Cancer Divideover 14 years ago
Financing R&D Through a Range of Consumer Productsover 14 years ago
New Year, New Issuesover 14 years ago
Innovation: Why is Pharma Scared to Death?over 14 years ago
Top Medical Innovations 2012over 14 years ago
Essential Questions for Essential Benefitsover 14 years ago
Copay Cards and Coupons: Letting the Facts Get in the Wayover 14 years ago
Pharma 2012: Hard Times Before the Harvestover 14 years ago
Here's to a Happier New Year?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5